Document Detail


Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart.
MedLine Citation:
PMID:  7926593     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The antagonism by glibenclamide of the effects of KRN2391, cromakalim and nifedipine on coronary flow (CF) were compared in isolated perfused rat hearts. 2. KRN2391, cromakalim and nifedipine increased CF in a concentration-dependent manner. In the presence of glibenclamide, the concentration-effect curves on CF for KRN2391 and cromakalim shifted to the right but that for nifedipine did not change. 3. The EC50 values increased about 6.6-fold for KRN2391 and 19.0-fold for cromakalim in the presence of glibenclamide. 4. These results suggest that the increase in CF induced by KRN2391 is due to both glibenclamide-sensitive and insensitive mechanisms.
Authors:
A Miwa; Y Jinno; T Yokoyama; T Izawa; N Ogawa
Related Documents :
20087453 - A dutch case of a takotsubo cardiomyopathy after pacemaker implantation.
1009543 - Pacemaker wenckebach phenomenon due to antiarrhythmic drug toxicity.
14656913 - Randomized comparison between stenting and off-pump bypass surgery in patients referred...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article    
Journal Detail:
Title:  General pharmacology     Volume:  25     ISSN:  0306-3623     ISO Abbreviation:  Gen. Pharmacol.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-11-10     Completed Date:  1994-11-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7602417     Medline TA:  Gen Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  471-4     Citation Subset:  IM    
Affiliation:
Pharmaceutical Research Laboratory, Kirin Brewery Co. Ltd., Gunma, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Benzopyrans / antagonists & inhibitors,  pharmacology
Coronary Circulation / drug effects*
Cromakalim
Dose-Response Relationship, Drug
Glyburide / pharmacology
Male
Nifedipine / antagonists & inhibitors,  pharmacology
Perfusion
Potassium Channels / drug effects*
Pyridines / antagonists & inhibitors,  pharmacology*
Pyrroles / antagonists & inhibitors,  pharmacology
Rats
Rats, Wistar
Vasodilator Agents / antagonists & inhibitors,  pharmacology*
Chemical
Reg. No./Substance:
0/Benzopyrans; 0/Potassium Channels; 0/Pyridines; 0/Pyrroles; 0/Vasodilator Agents; 10238-21-8/Glyburide; 134431-49-5/N-cyano-N'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate; 21829-25-4/Nifedipine; 94470-67-4/Cromakalim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of vanadium on L-ascorbic acid concentration in rat tissues.
Next Document:  Myocardial action potential prolongation by calcium channel activation under calcium-free EGTA condi...